Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening

Hepatocellular carcinoma is one of the malignancies worldwide with a high mortality rate and an increasing incidence. Molecular Targeted agents are its common first-line treatment. Organoid technology, as a cutting-edge technology, is gradually being applied in the development of therapeutic oncolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Cuiying, Gu, Ancheng, Khan, Muhammad, Yao, Xiangcao, Chen, Leping, He, Jiali, Yuan, Fumiao, Wang, Ping, Yang, Yufan, Wei, Yerong, Tang, Fang, Su, Hualong, Chen, Jiamin, Li, Jinxia, Cen, Bohong, Xu, Zhongyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853547/
https://www.ncbi.nlm.nih.gov/pubmed/36686807
http://dx.doi.org/10.3389/fonc.2022.1105454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853547/
https://www.ncbi.nlm.nih.gov/pubmed/36686807
http://dx.doi.org/10.3389/fonc.2022.1105454

Ejemplares similares